Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma(PRP) in Large to Massive Tears
1 other identifier
interventional
48
1 country
1
Brief Summary
- The purpose of this study is to compare the clinical and anatomical outcomes of rotator cuff repair with Platelet-Rich Plasma(PRP) and conventional rotator cuff repair in treatment of large to massive rotator cuff tears.
- PRP application to arthroscopic rotator cuff repair would accelerate recovery after arthroscopic rotator cuff repair in terms of pain relief, functional outcomes, overall satisfaction, and enhance structural integrity of repaired tendon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 8, 2010
CompletedFirst Posted
Study publicly available on registry
November 10, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFebruary 27, 2017
February 1, 2017
3.3 years
November 8, 2010
February 23, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
structural integrity of repaired rotator cuff tendon
To evaluate structural outcomes, magnetic resonance(MR)imaging or computed tomography arthrography were used at minimum postoperative 9months. The structural integrity was evaluated using Sugaya's method; * type I, sufficient thickness with homogenously low intensity * type II, insufficient thickness partial high intensity * type III, insufficient thickness without discontinuity (thinned cuff) * type IV, presence of minor discontinuity * type V, presence of a major discontinuity Type I, II, and III were considered as healed, while type IV, and V were considered as retear.
postoperative 9months
Study Arms (2)
Conventional group
PLACEBO COMPARATORPRP group
EXPERIMENTALInterventions
* Under general anesthesia, the patient was placed in the lazy lateral decubitus position on the operating table. * The surgical area was prepared and draped with Betadine. * Small stab incisions were made in the creation of 4-5 portals as needed. * A scope was explored via the arthroscopic portal into the GH joint \& subacromial space. * Repair of full thickness rotator cuff tear was done with suture anchors. * The skin was closed with Nylon or medical staples. * Sterile dressing was applied on surgical wound.
* Under general anesthesia, the patient was placed in the lazy lateral decubitus position on the operating table. * The surgical area was prepared and draped with Betadine. * Small stab incisions were made in the creation of 4-5 portals as needed. * A scope was explored via the arthroscopic portal into the GH joint \& subacromial space. * Repair of full thickness rotator cuff tear was done with suture anchors. * After tying sutures of the medial row, PRP gels were applied on the repair site. * The lateral row was secured using suture anchors. * The skin was closed with Nylon or medical staples. * Sterile dressing was applied on surgical wound.
Eligibility Criteria
You may qualify if:
- large to massive rotator cuff tear as a determined by clinical examination and MR prior to surgery.
You may not qualify if:
- previous history of shoulder surgery
- acute trauma
- chronic dislocation
- pyogenic infection
- rotator cuff arthropathy with glenohumeral osteoarthritis and superior migration of the humeral head
- showed abnormal serological test results
- thrombocytopenia (platelets less than 15000 per microliter)
- had been received anti-platelet medication
- psychiatric problems that precludes informed consent or inability to read or write
- other serious problems that preclude participation of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine
Seoul, 156-707, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chris Hyunchul Jo, M.D., Ph.D
Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, SMG-SNU Boramae Medical Center.
Study Record Dates
First Submitted
November 8, 2010
First Posted
November 10, 2010
Study Start
July 1, 2009
Primary Completion
October 1, 2012
Study Completion
December 1, 2012
Last Updated
February 27, 2017
Record last verified: 2017-02